Update on Administration Efforts on COVID-19 | March 23, 2020
Editor’s note: Here are the recent actions from the Trump administration on COVID. Note especially the FDA actions relaxing certain rules for ventilators and other
Editor’s note: Here are the recent actions from the Trump administration on COVID. Note especially the FDA actions relaxing certain rules for ventilators and other
CPA member Rosemary Gibson testified March 12, 2020 before the Senate Committee on Small Business and Entrepreneurship, 90 percent of America’s generic drug needs are currently
Editor’s note: China’s creeping colonialism is partially quantified as to Europe. For more than a decade, Chinese political and corporate leaders have been scouring the
Necessary response to mobilize US economy to fight pandemic Washington. The Coalition for a Prosperous America (CPA) strongly supports the Trump administration’s executive order enabling the Defense Production
CPA sent the following letter to President Trump today calling for an executive order to rebuild the drug and medical supply chain in the US
Excerpt: ““Beijing intends to use the global dislocation and downturn to attract foreign investment, to seize strategic market share and resources—especially those that force dependence, and to
Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of
Editor’s Note: Jeff Ferry is chief economist at the Coalition for a Prosperous America (CPA). Two decades of offshoring pharmaceuticals has hurt our national security. [Jeff
Editor’s note: The silver lining in the coronavirus outbreak is that calls for reshoring medical supplies and devices is becoming very strong. Which will help
Editor’s note: Michael Stumo asks, in this op-ed: Why do we let Chinese companies sell products made with forced labor in our market when we